Follow the Medicenna Therapeutics Corp. stock price and the full insider trade history of the company, a listed equity based in Canada. Shares trade on the CA market, under the supervision of SEDI. Market capitalisation: €42.5m. The latest transaction was reported on 2 June 2026 (15 - Acquisition or disposition under a prospectus). Among the most active insiders: Merchant, Fahar. All data is free.
14
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Medicenna Therapeutics Corp. Strong Buy (bullish), based on 3 analysts. Average price target: CA$3.20.
39Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.